We’re living through a genuine turning point in obesity medicine. After decades of telling patients to eat less and move more — advice that is correct but woefully incomplete — we finally have pharmaceutical tools that address the underlying biology of weight gain. But with more options comes more confusion, and I see that confusion play out in my practice every single week.
Patients come in having read one article that says medication is the answer and another that says it’s dangerous. The truth, as usual, is more nuanced. Here’s what I tell them.
Why Weight Loss Medication Exists
Obesity is a chronic, relapsing medical condition — not a lifestyle choice. The research on this is unambiguous. Genetic factors account for an estimated 40–70% of a person’s susceptibility to obesity. Hormonal systems governing hunger, satiety, fat storage, and energy expenditure vary significantly between individuals. Two people can eat the same diet and exercise the same amount and have very different outcomes.
Weight loss medication exists for the same reason blood pressure medication exists: because some conditions don’t resolve with lifestyle changes alone, and leaving them untreated has serious health consequences. Obesity is associated with type 2 diabetes, heart disease, sleep apnea, certain cancers, and reduced life expectancy. Treating it effectively is a medical priority.
The Major Categories of Weight Loss Medication
Not all weight loss medications work the same way, and understanding the differences matters.
GLP-1 receptor agonists are currently the most discussed category, and for good reason. Semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) mimic gut hormones that regulate hunger and blood sugar. They reduce appetite significantly, slow gastric emptying, and in clinical trials have produced average weight loss of 15–22% of body weight. These are the closest thing to a breakthrough the field has seen.
Older medications like phentermine, topiramate, and bupropion/naltrexone (Contrave) have been available longer and have a more established safety record for short- to medium-term use. They work through different mechanisms — primarily suppressing appetite through central nervous system pathways — and tend to produce more modest results, typically 5–10% body weight loss.
Orlistat works differently from all of the above: it blocks fat absorption in the gut. It produces modest weight loss but comes with well-documented gastrointestinal side effects that limit tolerability for many patients.
How to Think About Which Option Is Right for You
The right medication depends on more than your weight. I evaluate patients based on their metabolic markers, cardiovascular risk, history of disordered eating, other medications they’re taking, and their personal goals and preferences.
For patients with type 2 diabetes or cardiovascular disease, GLP-1 medications have proven benefits beyond weight loss — reduced cardiovascular events, improved glycemic control — making them a natural first choice. For patients who can’t tolerate injectables or for whom cost is a significant barrier, oral options may be more practical.
For a comprehensive overview of currently available weight loss medications, including how they compare and what to discuss with your doctor, it’s worth reviewing the latest evidence-based options before your next appointment.
What Medication Can’t Do
This is the part of the conversation I consider just as important as everything else. Weight loss medication is a tool, not a complete solution. The patients who see the best long-term outcomes are those who use medication to reduce the biological barriers to change — reduced hunger, improved energy, lower cravings — and simultaneously work on the behaviors that will sustain their health over time.
What does that look like in practice? Higher protein intake to preserve muscle mass. Some form of resistance training to protect metabolic rate. Attention to sleep and stress, both of which have measurable effects on weight. And in many cases, support from a dietitian, therapist, or health coach who understands the psychological complexity of changing eating patterns.
Medication can make the climb easier. It can’t replace the climb.
The Cost and Access Problem
I’d be remiss if I didn’t address the elephant in the room: cost. The newer GLP-1 medications can cost over $1,000 per month without insurance coverage, and coverage remains inconsistent even for patients with clear medical need. This is a significant and frustrating barrier.
Compounded versions of semaglutide have been available during shortage periods, though their regulatory status has been in flux. Generic versions of older medications like phentermine are far more affordable. And some newer oral GLP-1 options may expand access as the market evolves.
If cost is a barrier, have an honest conversation with your doctor about alternatives — don’t simply go without treatment for a condition that has real health consequences.
The Bottom Line
We are in the best moment in history to be seeking treatment for obesity. The medications available today are more effective and better tolerated than anything that came before. They’re not perfect, and they’re not for everyone — but for the right patient, they can be genuinely life-changing.
The goal isn’t just a lower number on the scale. It’s better metabolic health, reduced disease risk, more energy, and a relationship with food that doesn’t feel like a constant battle. Good medication, used thoughtfully alongside good habits and good medical supervision, can help get you there.
Dr. Quoc Dang is a board-certified physician and Medical Director of WeightLossPills.com, specializing in weight management and metabolic medicine. He works with patients nationwide to create personalized, evidence-based weight loss plans.
